Old Dominion Freight Line Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Old Dominion Freight Line Inc trades at $181.44 (market cap $36.42B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: Old Dominion Freight Line Inc is far larger — about 16× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Old Dominion Freight Line Inc pays a 0.66% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| ODFL | SLS | |
|---|---|---|
Market Cap | $36.42B | $2.28B |
Volume | 1,668,932 | 3,128,960 |
Sector | Industrials | Health |
52-Week High | $248.73 | $15.46 |
52-Week Low | $126.29 | $1.39 |
Typical Hold Time | 76 Days | — |
Enterprise Value | $36.15B | $2.15B |
Dividend Yield | 0.66% | — |
Signals from Pluang's Aura AI — not financial advice
Old Dominion Freight Line (ODFL) trades at $181.65, up 2.04% today, with a bearish technical signal despite recent earnings beats. The company maintains strong profitability with 19.44% net margins and 24.82% ROE, though revenue declined to $5.5B in 2025. Recent news highlights a 4.9% general rate increase effective October 5, 2026, aimed at offsetting operating costs while supporting service investments.
ODFL presents a mixed outlook with Wall Street's $230.93 consensus target suggesting 27% upside, yet technical indicators remain bearish. The stock's premium valuation (P/E 33.77) requires sustained earnings growth, while competitive pressures and freight demand volatility pose risks. Institutional buying and oversold technical conditions may support near-term recovery potential.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Old Dominion Freight Line is the fourth-largest less-than-truckload carrier in the United States, with more than 240 service centers and 9,200-plus tractors. OD is by far one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns stand head and shoulders above its peers. Strategic initiatives revolve around increasing network density through market share gains and maintaining industry-leading service via consistent infrastructure investment.
Read more on ODFL →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →